Endo International plc
Volume 164 · 164 F.T.C. 1083
Cite this decision
Endo International plc, 164 F.T.C. 1083 (2017). Consumer Law Library, https://consumerlawlibrary.org/decisions/v164-0030
Report an error in this record (decision id v164-0030)
Cited by 0 later FTC decisions
Cites
Text (OCR of the scan at left; may contain errors)
IN THE MATTER OF ENDO INTERNATIONAL PLC Docket No. C-4539. Order, October 27, 2017 Letter notifying Endo International plc of the Commission’s decision to waive prior approval and public comment regarding modifications to the supply agreement.
LETTER WAIVING PRIOR APPROVAL AND COMMENT FOR MODIFICATIONS TO A SUPPLY AGREEMENT Michael J. Sheerin, Esq.
Skadden, Arps, Slate, Meagher & Flom LLP Re: In the Matter of Endo International plc, Docket No. C-4539 Dear Mr. Sheerin:
This letter refers to an application for approval that Endo International plc filed on October 11, 2017, which requested Commission approval of a proposed amendment to the Supply Agreement, incorporated by reference into the Decision and Order entered into in this case.
After consideration of Endo’s application and pursuant to the authority delegated to me under Rule 2.41(f)(5)(ii) of the Commission’s Rules of Practice, 16 C.F.R. § 2.41(f)(5)(ii), I hereby waive the requirements for Commission approval and the public comment period for the amendment to the Supply Agreement between Vintage Pharmaceuticals, LLC d/b/a Qualitest Pharmaceuticals and Rising Pharmaceuticals, Inc., described in Endo’s application.
If you have further questions, please contact Ben Lorigo, the Compliance staff attorney assigned to this matter. Ben Lorigo can be reached at 202-326-3717 or [email protected]. VOLUME 164 Interlocutory Orders, Etc.